{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:38:27Z","timestamp":1792190307802,"version":"4.4.0"},"reference-count":20,"publisher":"American Diabetes Association","issue":"4","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,4,1]]},"abstract":"<jats:p>OBJECTIVE\u2014The purpose of this study was to evaluate safety and clinical efficacy of negative pressure wound therapy (NPWT) compared with advanced moist wound therapy (AMWT) to treat foot ulcers in diabetic patients.<\/jats:p>\n                  <jats:p>RESEARCH DESIGN AND METHODS\u2014This multicenter randomized controlled trial enrolled 342 patients with a mean age of 58 years; 79% were male. Complete ulcer closure was defined as skin closure (100% reepithelization) without drainage or dressing requirements. Patients were randomly assigned to either NPWT (vacuum-assisted closure) or AMWT (predominately hydrogels and alginates) and received standard off-loading therapy as needed. The trial evaluated treatment until day 112 or ulcer closure by any means. Patients whose wounds achieved ulcer closure were followed at 3 and 9 months. Each study visit included closure assessment by wound examination and tracings.<\/jats:p>\n                  <jats:p>RESULTS\u2014A greater proportion of foot ulcers achieved complete ulcer closure with NPWT (73 of 169, 43.2%) than with AMWT (48 of 166, 28.9%) within the 112-day active treatment phase (P = 0.007). The Kaplan-Meier median estimate for 100% ulcer closure was 96 days (95% CI 75.0\u2013114.0) for NPWT and not determinable for AMWT (P = 0.001). NPWT patients experienced significantly (P = 0.035) fewer secondary amputations. The proportion of home care therapy days to total therapy days for NPWT was 9,471 of 10,579 (89.5%) and 12,210 of 12,810 (95.3%) for AMWT. In assessing safety, no significant difference between the groups was observed in treatment-related complications such as infection, cellulitis, and osteomyelitis at 6 months.<\/jats:p>\n                  <jats:p>CONCLUSIONS\u2014NPWT appears to be as safe as and more efficacious than AMWT for the treatment of diabetic foot ulcers.<\/jats:p>","DOI":"10.2337\/dc07-2196","type":"journal-article","created":{"date-parts":[[2008,3,28]],"date-time":"2008-03-28T03:35:55Z","timestamp":1206675355000},"page":"631-636","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":472,"title":["Comparison of Negative Pressure Wound Therapy Using Vacuum-Assisted Closure With Advanced Moist Wound Therapy in the Treatment of Diabetic Foot Ulcers"],"prefix":"10.2337","volume":"31","author":[{"given":"Peter A.","family":"Blume","sequence":"first","affiliation":[{"name":"North American Center for Limb Preservation, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Walters","sequence":"additional","affiliation":[{"name":"Southern Arizona Veterans Affairs Medical Center, Surgery, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyatt","family":"Payne","sequence":"additional","affiliation":[{"name":"Institute for Tissue Regeneration, Repair, and Rehabilitation, Bay Pines VA Healthcare System, Bay Pines, Florida, and the University of South Florida, Division of Plastic Surgery, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Ayala","sequence":"additional","affiliation":[{"name":"Valley Baptist Hospital, Brownsville, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lantis","sequence":"additional","affiliation":[{"name":"Saint Luke's Roosevelt Hospital, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031218242238500_R1","unstructured":"Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2005"},{"key":"2022031218242238500_R2","doi-asserted-by":"crossref","unstructured":"Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, Wagner EH: Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care\u200822: 382\u2013387, 1999","DOI":"10.2337\/diacare.22.3.382"},{"key":"2022031218242238500_R3","doi-asserted-by":"crossref","unstructured":"Singh N, Armstrong DG, Lipsky BA: Preventing foot ulcers in patients with diabetes. JAMA\u2008293:217\u2013228, 2005","DOI":"10.1001\/jama.293.2.217"},{"key":"2022031218242238500_R4","doi-asserted-by":"crossref","unstructured":"Brem H, Shehan P, Rosenberg HJ, Schnieder JS, Boulton AJM: Evidence-based protocol for diabetic foot ulcers. Plast Reconstr Surg\u2008117:193S\u2013207S, 2006","DOI":"10.1097\/01.prs.0000225459.93750.29"},{"key":"2022031218242238500_R5","unstructured":"Mulder G, Armstrong D, Seaman S: Standard, appropriate, and advanced care and medical-legal considerations: part one\u2014diabetic foot ulcerations. Wounds\u200815:92\u2013106, 2003"},{"key":"2022031218242238500_R6","unstructured":"Guideline for Management of Wounds in Patients with Lower-Extremity Arterial Disease. Glenview, IL, Wound Ostomy and Continence Nurses Society, 2002"},{"key":"2022031218242238500_R7","doi-asserted-by":"crossref","unstructured":"Martson WA, Hanft J, Norwood P, Pollak R: The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of prospective randomized trial. Diabetes Care\u200826:1701\u20131705, 2003","DOI":"10.2337\/diacare.26.6.1701"},{"key":"2022031218242238500_R8","doi-asserted-by":"crossref","unstructured":"Veves A, Falanga V, Armstrong DA, Sabolinski ML: Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care\u200824:2001\u2013295, 2001","DOI":"10.2337\/diacare.24.2.290"},{"key":"2022031218242238500_R9","unstructured":"Robson MC, Payne WG, Garner WL, Biundo J, Giacalone VF, Cooper DM, Ouyang P: Integrating the results of phase IV (postmarketing) clinical trial with four previous trials reinforces the position that Regranex (becaplermin) gel 0.01% is an effective adjunct to the treatment of diabetic foot ulcers. J Appl Res\u20085:35\u201345, 2005"},{"key":"2022031218242238500_R10","unstructured":"Mannari RJ, Payne WG, Ochs DE, Walusimbi M, Blue M, Robson MC: Successful treatment of recalcitrant, diabetic heel ulcers with topical becaplermin (rhPDGF-BB) gel. WOUNDS\u200814:116\u2013121, 2002"},{"key":"2022031218242238500_R11","doi-asserted-by":"crossref","unstructured":"Peters EJ, Lavery LA, Armstrong DG, Fleischli JG: Electric stimulation as an adjunct to heal diabetic foot ulcers: a randomized clinical trial. Arch Phys Med Rehabil\u200882:721\u2013725, 2001","DOI":"10.1053\/apmr.2001.23780"},{"key":"2022031218242238500_R12","doi-asserted-by":"crossref","unstructured":"Argenta LC, Morykwas MJ: Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg\u200838:563\u2013576, 1997","DOI":"10.1097\/00000637-199706000-00002"},{"key":"2022031218242238500_R13","doi-asserted-by":"crossref","unstructured":"Wagner, FW: The dysvascular foot: a system for diagnosis and treatment. Foot Ankle\u20082:64\u2013122, 1981","DOI":"10.1177\/107110078100200202"},{"key":"2022031218242238500_R14","unstructured":"V.A.C. Therapy Clinical Guidelines. A Reference Source for Clinicians. KCI, San Antonio, TX; 2004"},{"key":"2022031218242238500_R15","unstructured":"Guidance for Industry. Chronic Cutaneous Ulcer and Burn Wounds\u2014Developing Products for Treatment (Draft Guidance). Rockville, MD, U.S. Department of Health and Human Services, 2000, p. 15"},{"key":"2022031218242238500_R16","unstructured":"Sibbald RG, Torrance G, Hux M, Attard C, Milcovich N: Cost-effectiveness of becaplermin for non-healing neuropathic diabetic foot ulcers. Ostomy Wound Manage\u200843:76\u201384, 2003"},{"key":"2022031218242238500_R17","doi-asserted-by":"crossref","unstructured":"Hopf HW, Humphrey LM, Puzziferri N, West JM, Attinger CE, Hunt TK: Adjuncts to preparing wounds for closure: hyperbaric oxygen, growth factors, skin substitutes, negative pressure wound therapy (vacuum assisted closure). Foot Ankle Clin\u20086:661\u2013682, 2001","DOI":"10.1016\/S1083-7515(02)00008-6"},{"key":"2022031218242238500_R18","doi-asserted-by":"crossref","unstructured":"Saxena V, Hwang CW, Huang S, Eichbaum Q, Ingber D, Orgill DP: Vacuum-assisted closure: microdeformations of wounds and cell proliferation. Plast Reconstr Surg\u2008114:1086\u20131096, 2004","DOI":"10.1097\/01.PRS.0000135330.51408.97"},{"key":"2022031218242238500_R19","doi-asserted-by":"crossref","unstructured":"Greene AK, Puder M, Roy R, Arsenault D, Kwei S, Moses MA, Orgill DP: Microdeformational wound therapy: effects on angiogenesis and matrix metalloproteinases in chronic wounds of 3 debilitated patients. Ann Plast Surg\u200856:418\u2013422, 2006","DOI":"10.1097\/01.sap.0000202831.43294.02"},{"key":"2022031218242238500_R20","doi-asserted-by":"crossref","unstructured":"Armstrong DF, Lavery LA: Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet\u2008366:1704\u20131710, 2005","DOI":"10.1016\/S0140-6736(05)67695-7"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/4\/631\/599137\/zdc00408000631.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/4\/631\/599137\/zdc00408000631.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T14:25:02Z","timestamp":1647095102000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/31\/4\/631\/25665\/Comparison-of-Negative-Pressure-Wound-Therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc07-2196","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,1]]}}}